Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Mologen begins lefitolimod’s Phase IIa trial to treat HIV

HIV
Scanning electron micrograph of an HIV-infected H9 T cell. Credit: NIAID.